Hemos actualizado nuestra política de privacidad. Haga clic aquí para revisar los detalles. Pulse aquí para revisar los detalles
Active su período de prueba de 30 días gratis para desbloquear las lecturas ilimitadas.
Active su período de prueba de 30 días gratis para seguir leyendo.
Descargar para leer sin conexión
Transdermal drug delivery systems (TDDS), also known as "patches," are dosage forms designed to deliver a therapeutically effective amount of drug across a patient's skin. The adhesive of the transdermal drug delivery system is critical to the safety, efficacy and quality of the product. In the Drug Quality Reporting System (DQRS), the United States Food and Drug Administration (FDA) has received numerous reports of "adhesion lacking" for transdermal drug delivery systems. This article provides an overview of types of transdermals, their anatomy, the role of adhesion, the possible adhesion failure modes and how adhesion can be measured. Excerpts from FDA reports on the lack of adhesion of transdermal system products are presented. Pros and cons of in vitro techniques, such as peel adhesion, tack and shear strength, in vivo techniques used to evaluate adhesive properties are discussed. To see a decrease in "adhesion lacking" reports, adhesion needs to become an important design parameter and suitable methods need to be available to assess quality and in vivo performance. This article provides a framework for further discussion and scientific work to improve transdermal adhesive performance.
Transdermal drug delivery systems (TDDS), also known as "patches," are dosage forms designed to deliver a therapeutically effective amount of drug across a patient's skin. The adhesive of the transdermal drug delivery system is critical to the safety, efficacy and quality of the product. In the Drug Quality Reporting System (DQRS), the United States Food and Drug Administration (FDA) has received numerous reports of "adhesion lacking" for transdermal drug delivery systems. This article provides an overview of types of transdermals, their anatomy, the role of adhesion, the possible adhesion failure modes and how adhesion can be measured. Excerpts from FDA reports on the lack of adhesion of transdermal system products are presented. Pros and cons of in vitro techniques, such as peel adhesion, tack and shear strength, in vivo techniques used to evaluate adhesive properties are discussed. To see a decrease in "adhesion lacking" reports, adhesion needs to become an important design parameter and suitable methods need to be available to assess quality and in vivo performance. This article provides a framework for further discussion and scientific work to improve transdermal adhesive performance.
Parece que ya has recortado esta diapositiva en .
¡Acabas de recortar tu primera diapositiva!
Los recortes son una forma práctica de recopilar diapositivas importantes para volver a ellas más tarde. Ahora puedes personalizar el nombre de un tablero de recortes para guardar tus recortes.La familia SlideShare crece. Disfruta de acceso a millones de libros electrónicos, audiolibros, revistas y mucho más de Scribd.
Cancela en cualquier momento.Lecturas ilimitadas
Aprenda más rápido y de forma más inteligente con los mejores expertos
Descargas ilimitadas
Descárguelo para aprender sin necesidad de estar conectado y desde cualquier lugar
¡Además, tiene acceso gratis a Scribd!
Acceso instantáneo a millones de libros electrónicos, audiolibros, revistas, podcasts y mucho más.
Lea y escuche sin conexión desde cualquier dispositivo.
Acceso gratis a servicios prémium como TuneIn, Mubi y muchos más.
Hemos actualizado su política de privacidad para cumplir con las cambiantes normativas de privacidad internacionales y para ofrecerle información sobre las limitadas formas en las que utilizamos sus datos.
Puede leer los detalles a continuación. Al aceptar, usted acepta la política de privacidad actualizada.
¡Gracias!